The influence of biallelic polymorphisms in the tumour necrosis factor-alpha (TNF␣), lymphotoxin-alpha (LT␣) and interleukin-10 (IL-10) genes on stimulated TNF␣ and IL-10 production was studied in ulcerative colitis (UC) patients, Crohn's disease (CD) patients and in healthy controls. A polymerase chain reaction sequence-specific primer (PCR-SSP) system was developed to type nine biallelic polymorphisms, three in each of the TNF␣, LT␣ and IL-10 genes. Production of the TNF␣ and IL-10 was measured by ELISA in lipopolysaccharide (LPS) stimulated whole blood. Four haplotypes of the TNF␣ gene, three haplotypes of LT␣ and three haplotypes of IL-10 were identified. No significant differences in haplotype frequencies were found between patients and controls overall. On subgroup analysis however, haplotype TNF-2 was more frequent in women with extensive colitis compared to distal colitis (31% vs 12%; P = 0.028). This difference was even greater for the combined TNF-2-LT␣-2 haplotype (56% vs 21%; P = 0.0007). The TNF-2 and LT␣-2 haplotypes were associated with higher TNF␣ production in CD patients, and the TNF-4 haplotype was associated with lower TNF␣ production in UC patients. The A allele in the IL-10 promoter region at position −1082 was associated with decreased IL-10 production in CD patients and controls (P = 0.005, P = 0.015 respectively). These data provide evidence that the effect of TNF␣, LT␣ and IL-10 gene polymorphisms on cytokine production differ in CD, UC patients and controls. Genes and Immunity (2000) 1, 185-190. 
Introduction
Tumour necrosis factor-alpha (TNF␣) is a potent proinflammatory and immunoregulatory cytokine that plays a key role in the initiation, regulation and perpetuation of the inflammatory response, whereas interleukin-10 (IL-10) inhibits the production of the pro-inflammatory cytokines (IL-1, TNF␣, IFN-␥ and IL-6) through its action on Th1 cells and macrophages. [1] [2] [3] The close interrelationships between TNF␣ and IL-10 have been confirmed in several studies. 4, 5 Another possible interacting cytokine is lymphotoxin-alpha (LT␣), which shares the same receptors with TNF␣ and also maps in the HLA class III region on the short arm of chromosome 6. Stable TNF␣ production, varying less than 15%, has been described, when single individuals are sampled over time. 6 This makes comparisons between individuals more meaningful. Studies on monozygotic twins and their first-degree relatives, using ex vivo endotoxin stimulated whole blood samples, provide evidence that 60% of TNF␣ and 75% of IL-10 variation in production capacity appears to be genetically determined.
IL-10 also has proven relevance to IBD since knockout of the IL-10 gene induces chronic enterocolitis in mice. 9 The concentration of IL-10 has been reported to be increased in patients with both active ulcerative colitis (UC) and active CD when compared to healthy controls. 10 This study tests the hypothesis that the cytokine profile may be imbalanced in IBD due to both monocyte activation and genetic polymorphism.
Results

TNF␣ and LT␣ polymorphisms
Four haplotypes of the three polymorphisms in the TNF␣ gene and three haplotypes of the three polymorphisms in the LT␣ gene were identified in the examined population (Table 1 ). There were no significant differences in frequencies of the biallelic polymorphisms or whole haplotypes between controls, CD and UC patients (Table 2) . When subgroups of patients were analysed, haplotype TNF-2 was more frequent in women with extensive compared to distal colitis (31% vs 12%, P = 0.028). When analysed for the combined haplotype TNF-2-LT␣-2, the association became stronger (21% vs 56%, P = 0.0007). There was strong linkage disequilibrium between TNF-2 
IL-10 polymorphisms
The three biallelic polymorphisms of the IL-10 gene occurred in only three haplotypes (Table 1) . No significant differences in allele or haplotypes frequencies were observed between the patients and controls ( Table 2) .
Effect of medication on TNF␣ and IL-10 production TNF␣ and IL-10 production was measured in lipopolysaccharide (LPS)-stimulated blood taken from a randomly selected group of 52 controls and 136 IBD patients. Large intra-individual differences in LPS-stimulated whole blood production of cytokines were observed. No effect on the number of white blood cells (WBC) in the blood samples and stimulated TNF␣ or IL-10 production was observed. In IBD patients, steroid treatment significantly decreased LPS-stimulated TNF␣ secretion (1418 ± 1799 vs 5612 ± 1972 pg/mL, P = 0.013). No significant effect on LPS-stimulated TNF␣ secretion was observed in patients treated with 5-aminosalicylic acid (5-ASA) or sulphasalazine.
UC patients treated with 5-aminosalicylic acid (5-ASA) or sulphasalazine (SLSZ) had higher IL-10 production than those without any medication (198 ± 45 vs 164 ± 54 pg/mL, P = 0.042). CD patients treated with prednisolone had lower IL-10 production than those without any medication (46.5 ± 17 vs 111 ± 46 pg/mL, P = 0.038). A similar effect of steroids was observed in UC patients but the difference was not significant, perhaps due to the fact that all patients were receiving 5-ASA.
Effect of CD, UC and smoking on TNF and IL-10 production The LPS-stimulated TNF␣ production was higher in controls than in the group of 47 CD or 49 UC patients without steroid treatment (Controls: 8958 ± 1978 pg/mL vs CD: 4791 ± 1819 pg/mL, P = 0.0045 or vs UC: 6028 ± 2393 pg/mL, P = 0.015). Also LPS-stimulated IL-10 production was higher in controls than in UC (P = 0.012) or CD patients (Controls: 235 ± 108 pg/mL vs UC: 164 ± 69 pg/mL; P = 0.012 or vs CD: 123 ± 43 pg/mL, P = 0.023).
Smokers with CD showed higher stimulated IL-10 protein production in whole blood than non-smokers (208 ± 76 pg/mL vs 105 ± 34 pg/mL, P = 0.011). This was not apparent in healthy controls (281 ± 111 pg/mL vs 220 ± 78 pg/mL) and UC patients (176 ± 76 pg/mL vs 158 ± 68 pg/mL).
There was a tendency towards lower LPS-stimulated TNF␣ production in UC patients with extensive colitis compared with distal colitis (4024 ± 1760 vs 6584 ± 1665 pg/mL), and a tendency towards lower TNF␣ production in CD patients with colonic involvement compared with ileitis (3784 ± 1671 vs 5340 ± 1891 pg/mL). However, these differences did not reach statistical significance.
TNF␣ and LT␣ polymorphisms and TNF␣ production
Since steroids have been shown to suppress TNF␣ and IL-10 release from circulating mononuclear cells, functional analysis of TNF␣, LT␣ and IL-10 polymorphisms were performed in patients who had not received steroid treatment for at least a month prior to assay.
In CD patients, TNF-2 or LT␣-2 haplotypes were associated with higher TNF␣ production (TNF-2: 6383 ± 828 vs 3890 ± 1544 pg/mL, P = 0.003; LT␣-2: 6039 ± 1322 vs 3487 ± 2142 pg/mL, P = 0.002). However, in controls the LT␣-2 haplotype was associated with lower TNF␣ production (8458 ± 1810 vs 10731 ± 2044 pg/mL, P = 0.012). In UC patients a lower production of TNF␣ was seen in association with the TNF-4 haplotype (Table 3) .
IL-10 polymorphism and IL-10 production
Due to the stimulating effect of 5-ASA, SLSZ and the suppressing effect of prednisolone on IL-10 production, data were analysed from patients not receiving medication. Stimulated IL-10 production in controls and CD patients homozygous for IL 10 (−1082) A was lower than those homozygous for IL 10 (−1082) G (Controls: 164 ± 71 vs 315 ± 130 pg/mL, P = 0.015; CD: 62 ± 19 vs 178 ± 30 pg/mL, P = 0.005) ( Table 4) . Controls carrying IL10 ATA haplotype showed lower stimulated IL-10 production 187 Differences in cytokine production between groups were examined with the Kruskal-Wallis test. A P value less than 0.05 was considered statistically significant (*). (**) -represent corrected P value for multiple comparisons Table 4 The effect of biallelic polymorphisms in the promoter region of IL-10 gene on IL-10 (pg/mL) production in whole blood samples stimulated with LPS for 24 h. Results are expressed as median with semi-interquartile range. Results were analysed in the group of ulcerative colitis (UC), Crohn's disease (CD) patients who were not taking any medications; including steroids and 5-ASA Differences in cytokine production between groups were examined with the Kruskal-Wallis test. A P value less than 0.05 was considered statistically significant (* a P = 0.015, **P = 0.045; * b P = 0.015, **P = 0.045; * c P = 0.015, **P = 0.045; * d P = 0.005, **P = 0.015). (**P), represent corrected P value for multiple comparison.
Genes and Immunity compared to controls not carrying IL10 ATA haplotype (207 ± 88 vs 286 ± 133 pg/mL, P = 0.015). Both controls and CD patients with IL-10 GCC haplotype presented higher stimulated IL-10 levels (Controls: 278 ± 92 vs 166 ± 71 pg/mL, P = 0.015; CD: 157 ± 92 vs 62 ± 19 pg/mL, P = 0.005) ( Table 5) . No functional effect of the IL-10 promoter polymorphism was observed in UC patients.
Relationship between IL-10 and TNF␣ protein production A correlation was observed between IL-10 and TNF␣ production in UC patients who were not undergoing any course of medication (P = 0.016). No correlation was observed between IL-10 and TNF␣ production in controls or CD patients.
Discussion
The present paper represents a comprehensive study on the significance of TNF␣, LT␣ and IL-10 polymorphisms in IBD patients and healthy controls. Using a polymerase chain reaction sequence-specific primer (PCR-SSP) system with a 3Ј mismatches in the forward and reverse primers, physically linking polymorphic alleles as haplotypes, 'haplotypes' of the TNF␣ gene, the LT␣ gene and the IL-10 gene were identified in a group of 199 IBD patients and 236 controls. The functional effects of these identified haplotypes were analysed in an ex vivo system of whole blood to mimic as closely as possible the in vivo situation and the complexity of cytokine and cell network interactions. The kinetics of cytokine production under such conditions is comparable to that in healthy individuals after an intravenous injection of single dose of LPS. 4, 11, 12 Any isolation procedure for peripheral blood mononuclear cells (PBMC) may leave variable proportions of neutrophils which can themselves produce cytokines such as TNF␣ or play a role in the intercellular communications that may up-regulate cytokine production by other cells. 13, 14 The separation procedure of PBMC may also activates and eliminates a proportion of monocytes and thereby modify the lymphocyte/ monocyte ratio. Thus, whole non-diluted blood represents a more physiological environment for examining endotoxin stimulated cytokine production, not only due to the preserved cellular interactions but also because of the presence of plasma factors such as soluble CD14 and LPS binding proteins. 15, 16 The incubation of whole blood with LPS has been shown to be influenced by heparin, which increases the level of stimulated TNF␣ production by an order of magnitude. 17 To avoid this extra stimulant, a siliconised tube containing sodium citrate was used.
The results show no significant differences in the frequencies of TNF␣, LT␣ and IL-10 haplotypes between control individuals, CD and UC patients overall. However, when subgroups of women with UC were analysed, the combined haplotype of TNF-2-LT␣-2 was found three times more frequently in extensive colitis compared to distal colitis. This implies that cytokine polymorphisms may have a role in determining extent of disease in UC. We have already shown a modest decrease in the frequency of the TNF␣(−308)*2 allele, which is included in the TNF␣-2 haplotype, in females with distal colitis, when compared to males with distal colitis. The results are consistent with our earlier observation that the DR3 DQ2 haplotype, known to be associated with TNF␣(−308)*2 and LT␣ (NcoI)*1, is reduced in females with distal colitis. 18 Data from the second part of this study show differential effects of TNF␣ and LT␣ polymorphisms on TNF␣ production in patients with Crohn's disease, ulcerative colitis and healthy controls. Whereas in controls, TNF-2 and LT␣-2 haplotypes were associated with lower production, the same haplotypes in CD patients were associated with higher TNF␣ production. We hypothesised that this difference might be due to IL-10 either at the level of polymorphism or production since abundant evidence exists for the control of TNF␣ level by IL-10. 19, 20 Although there were no significant differences in allele or haplotype frequencies of IL-10 between patients or patient groups and controls, the A allele in the IL-10 promoter region at position −1082 was associated with decreased IL-10 production in CD patients and controls. The IL-10 ATA haplotype was also associated with lower production in controls. These results are consistent with the observation by Turner et al, 21 that an A at position −1082 is associated with lower production. The recent study of Crawley et al 22 also demonstrates functional significance of the ATA haplotype, which was associated with lower IL-10 production and extended oligoarthritis. It has also been shown that the IL-10 ATA haplotype is associated with neuropsychiatric manifestations in patients with SLE. 23 We have observed strong influences of smoking and drug regimes on the levels of IL-10 produced. Specifically in CD patients, smoking raised IL-10 levels towards the level observed in normal controls. In UC the same trend was observed but the results did not approach significance. Smoking is well known to be more prevalent among patients with Crohn's disease and there may be a biological connection between this fact and our results. Patients undergoing steroid therapy have shown decreased IL-10 and TNF␣. This is in agreement with previous studies showing that steroids broadly attenuate cytokine production not only of pro-inflammatory TNF␣, but also of the anti-inflammatory IL-10. 24 Interestingly, we observed that 5-ASA usage was associated with higher IL-10 secretion and like smoking could therefore act through a feedback control.
In conclusion these data provide evidence that the effects of gene polymorphisms on cytokine production for TNF␣, LT␣ and IL-10 differ in CD and UC patients when compared with normal individuals. The explanation for this is unknown at present but strongly suggests the presence of functionally effective polymorphisms in genes that participate directly in the TNF␣ and IL-10 feedback.
Materials and methods
Subjects
A group of 111 UC and 91 CD patients with no family history of IBD was randomly selected from Caucasian adult patients attending the Gastroenterology Clinic at the John Radcliffe Hospital in Oxford. Clinical data were obtained by questionnaire, personal interviews and review of case records. The diagnosis of CD or UC was made on the basis of clinical, radiological and histopathological data, according to standard criteria. UC disease activity was assessed using the Sutherland score, 25 whereas the Crohn's disease activity index (CDAI) 26 helped define CD patients. The extent of disease was defined using the most recent investigation (barium enema or colonoscopy) and was classified in UC patients as extensive when it was proximal to the splenic flexure or as distal when it was distal to the splenic flexure. Three patients with 'indeterminate' colitis were excluded from this study. Demographic data and clinical characteristics of patients with inflammatory bowel disease are summarised in Table 6 .
A group of 236 unrelated healthy individuals and cadavers donors (95 females; 141 males) belonging to the Oxfordshire population were studied for polymorphisms. Cytokine production was measured in 56 of them (26 females; 30 males). On the afternoon of blood sampling, all healthy individuals had a normal oral temperature and had not undergone intensive physical exercise in the previous 24 h.
Whole blood stimulation and DNA extraction
Four and a half millilitres of peripheral venous blood were collected into siliconised 'Vacutainer' tubes containing 0.105 m sodium citrate. Whole, undiluted blood was incubated at 37°C in 5% CO 2 for 24 h with 10 g/mL of LPS (E. coli serotype 055:B5). All samples were gently inverted during incubation. Plasma was separated from whole blood cultures following stimulation for 24 h and stored at −70°C until assayed by ELISA. DNA from the Genes and Immunity remaining white blood cells was extracted using a conventional proteinase K (Boehringer Mannheim, Mannheim, Germany) digestion of isolated cells, followed by phenol extraction and ethanol precipitation.
Typing TNF␣ and LT␣ polymorphisms
The following TNF␣ and LT␣ gene biallelic polymorphisms were studied: G/A at position −238 and −308 in TNF␣ promoter region, G/A at position +488 in the first intron of TNF␣ gene, G/A at position +249 (NcoI RFLP) in the first intron of LT␣ gene, G/C polymorphism at position +365 (Asp-H1 RFLP) in the first intron of LT␣ gene and C/A polymorphism at position +720 (amino acid polymorphism AA26) in the third intron of LT␣ gene. They were typed by a 24 reaction system based on 3Ј mismatches in the forward and reverse primers as previously published. 27 The haplotypes for TNF␣ and LT␣ were assigned separately.
Typing IL-10 polymorphisms
Three polymorphisms in the IL-10 promoter region at positions −1082 (G/A), −819 (C/T), and −592 (C/A) were typed by 12 reactions as described previously. 28 The advantage of these strategies is that polymorphisms are physically linked through PCR and haplotypes can be determined unequivocally without the use of families.
Measurement TNF␣ and IL-10 secretion
Plasma soluble TNF␣ and IL-10 were measured by R&D Systems ELISA kits-Quantokine TNF␣ (range of detection 15.6-1000 pg/mL) and Quantokine IL-10 (range of detection 7.8-500 pg/mL) as described by the manufacturer. Plasma samples were diluted 1:40 for TNF␣ and 1: 20 for IL-10 with Quantokine Calibrator Diluents. All samples were analysed in duplicate.
Statistical analysis
The results of cytokine production are expressed as median with semi-interquartile range. Differences in cytokine production between groups were examined using the Kruskal-Wallis test. Fisher's exact test was performed for the comparison of genotypes or allele frequencies.
Spearman's test was used to calculate correlation coefficients between IL-6 and IL-10 or TNF␣ production. A P value less than 0.05 was considered statistically significant. Table 3 , 4 and 5 contain P values corrected for multiple comparisons.
